< Zurück zu den wissenschaftlichen Publikationen

Magazin 2,4

Daclatasvir, Sofosbuvir with or without Ribavirin for 24 weeks in hepatitis C genotype 3 cirrhosis: A real-life study.

Autoren: lionetti R

Datum: Mai 2019

Interessensgebiet: infektiös/hepatologisch




Das könnte Sie auch interessieren:

Magazin 14.17

Correction to: Adjunctive Brivaracetam in Focal Epilepsy: Real‑World Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST).

Autoren: Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Chiesa V, Dainese F, De Maria G, Didato G, Falcicchio G, Fanella M, Ferlazzo E, Fisco G, Gangitano M, Giallonardo AT, Giorgi FS, La Neve A, Mecarelli O, Montalenti E, Piazza F, Pulitano P, Quarato PP, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAFIRST Group Membership.

Datum: 2021

Interessensgebiet: Epilepsie


Details lesen
Magazin 17.152

Diabetes Affects Antibody Response to SARS-CoV-2 Vaccination in Older Residents of Long-Term Care Facilities: Data From the GeroCovid VAX Study.

Autoren: Virgilio E, Trevisan C, Abbatecola A, Malara A, Palmieri A, Fedele G, Stefanelli P, Leone P, Schiavoni I, Maggi S, Volpato S, Antonelli Incalzi R, Onder G; GeroCovid Vax Working Group; GeroCovid Vax Working Group.

Datum: 2022

Interessensgebiet: diabetes


Details lesen
Magazin

A case of metachronousperipheral T-Cell non-Hodgkin lymphoma following chemotherapy for Hodgkin diseasesuccessfullytreated with Brentuximab Vedotin

Autoren: Meconi F,Provenzano I, Nasso D, Mariotti B, Pupo L, Secchi R, Cerretti R, Lucia A, Arcese W, Cantonetti M

Datum: 2020

Interessensgebiet: Hämatologie


Details lesen